HYDROmorphone in 0 — Class II drug recall D-1044-2023
Terminated recall by Central Admixture Pharmacy Services Inc, reported 2023-08-09, distributed nationwide. Lack of assurance of sterility: Lack of validation data for sanitization cycles
| Recall number | D-1044-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Central Admixture Pharmacy Services Inc, San Diego, CA, United States |
| Recall initiated | 2023-07-17 |
| Classified | 2023-08-03 |
| Reported by FDA | 2023-08-09 |
| Terminated | 2025-03-21 |
| Distributed | Nationwide (US) |
| Quantity | 2,717 syringes |
| Reason classes | sterility |
| NDC | 71286-2010-01 |
| Lot numbers | 17-270603, 17-270802, 17-271073, 17-271129, 17-271254, 17-271953, 17-272022, 17-272295, 17-272616, 17-273357, 17-273501 |
| Expiration dates | 2023-07-17, 2023-07-19, 2023-07-24, 2023-07-25, 2023-07-26, 2023-08-08, 2023-08-09, 2023-08-14, 2023-08-20, 2023-08-31, 2023-09-04 |
Product
HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2010-1
Reason for recall
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1044-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.